Similar articles

• High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.

  Djerassi I, Kim JS, Shulman K. Djerassi I, et al. Cancer Treat Rep. 1977 Jul;61(4):691-4. Cancer Treat Rep. 1977. PMID: 301782 No abstract available.
• Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics.

  Abelson HT, Ensminger W, Rosowsky A, Uren J. Abelson HT, et al. Cancer Treat Rep. 1978 Oct;62(10):1549-52. Cancer Treat Rep. 1978. PMID: 309355
• [Massive dose methotrexate with citrovorum factor rescue: MTX-pharmacokinetics, excretion pattern, and techniques for safety administration (author's transl)].

  Sasaki K, Fujimoto T. Sasaki K, et al. Nihon Gan Chiryo Gakkai Shi. 1979 Oct 20;14(6):988-96. Nihon Gan Chiryo Gakkai Shi. 1979. PMID: 317293 Japanese. No abstract available.
• Anti-folate resistance in leukemia: treatment with "high-dose" methotrexate and citrovorum factor.

  Bender RA. Bender RA. Cancer Treat Rev. 1975 Sep;2(3):215-24. doi: 10.1016/s0305-7372(75)80004-1. Cancer Treat Rev. 1975. PMID: 1104164 Review. No abstract available.
• Methotrexate. II. Use in pediatric chemotherapy.

  Lippens RJ. Lippens RJ. Am J Pediatr Hematol Oncol. 1984 Winter;6(4):397-413. Am J Pediatr Hematol Oncol. 1984. PMID: 6398630 Review.